Brief Introduction of Shanghai Laishi Blood Products Co., Ltd.

The main products of Shanghai Lai Shi are human serum albumin, intravenous human immunoglobulin (pH4), human coagulation factor VIII, human prothrombin complex, human fibrinogen, freeze-dried human thrombin and freeze-dried fibrin adhesive for external use, with 23 specifications. Shanghai Lai Shi strictly follows the requirements of good manufacturing practice (GMP) issued by SFDA. It is the first batch of blood products enterprises in China that have passed GMP certification, and it follows the regulations of the US Food and Drug Administration (FDA), the guiding principles of the World Health Organization (WHO) and the requirements of the US Pharmacopoeia and the European Pharmacopoeia. In June 2000, 1 1, the company successfully passed the ISO900 1 certification, and it is the first blood product enterprise in China to pass the ISO900 1 quality system certification.